Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction.
Kraehenbuehl
Thomas P
TP
Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Room E25-342, Cambridge, MA 02139, USA.
Ferreira
Lino S
LS
Hayward
Alison M
AM
Nahrendorf
Matthias
M
van der Vlies
André J
AJ
Vasile
Eliza
E
Weissleder
Ralph
R
Langer
Robert
R
Hubbell
Jeffrey A
JA
D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry / Q000378:metabolism; D002470:Cell Survival; D053595:Embryonic Stem Cells / Q000166:cytology / Q000502:physiology*; D006801:Humans; D020100:Hydrogels / Q000737:chemistry / Q000378:metabolism; D008422:Materials Testing; D020778:Matrix Metalloproteinase 2 / Q000235:genetics / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000235:genetics / Q000378:metabolism; D009203:Myocardial Infarction / Q000473:pathology*; D009206:Myocardium / Q000473:pathology*; D032383:Myocytes, Cardiac / Q000473:pathology; D051381:Rats; D012038:Regeneration / Q000502:physiology; D013947:Thymosin / Q000008:administration & dosage / Q000378:metabolism; D023822:Tissue Engineering / Q000379:methods*; D019737:Transplants; D000099201:Thymosin beta(4)
D001672:Biocompatible Materials; D020100:Hydrogels; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D013947:Thymosin; D000099201:Thymosin beta(4)